Recursion · 2 hours ago
Head of Early Discovery
Salt Lake City, Utah
Full-time
Hybrid
Director/Executive
$229K/yr - $275K/yr
10+ years expRecursion Pharmaceuticals is a clinical stage TechBio company focused on improving lives through innovative drug discovery. The Head of Early Discovery will lead strategic initiatives to accelerate drug discovery by leveraging advanced technologies and data-driven approaches while managing a multidisciplinary team to drive impactful therapies for patients.
Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics
Responsibilities
Define and execute the early discovery strategy aligned with company objectives
Champion modern methodologies, including AI and computational approaches, to enhance decision-making and streamline workflows
Effective communication and clear decision making
Foster a culture of urgency and patient-centric innovation
Lead and inspire a multidisciplinary, international team of scientists and research associates
Manage cross-functional collaborations with internal teams and external partners, including academic institutions, pharmaceutical companies and key opinion leaders
Oversee target identification, validation, and mechanism-of-action studies
Support translation of early stage programs into the broader portfolio including preclinical and early clinical development stages
Implement high-quality, efficient, data-driven decision-making processes to prioritize assets and allocate resources effectively
Spearhead initiatives to integrate advanced cellular and biochemical technologies, functional genomics platforms and fit-for-purpose screening systems
Embrace novel approaches to accelerate discovery, validate targets effectively, and ensure programs are data driven
Qualification
Required
PhD in Biology or related discipline
10+ years of postdoctoral experience in oncology & immunology. Additional disease area experience is a plus
Proven track record in target identification, validation, and translation into later stages of drug discovery. Experience advancing programs from early discovery through IND enabling studies
Demonstrated ability to embrace and implement modern technologies (e.g., AI) in drug discovery
Strong strategic thinking and commitment to scientific rigor
Exceptional communication and leadership skills
Preferred
Early-stage clinical program involvement for a holistic view of drug development
Expertise in contemporary small molecule discovery; experience with other modalities is a bonus
Familiarity with immunology / immuno-oncology and/or other disease areas
Benefits
Annual bonus
Equity compensation
Comprehensive benefits package
Company
Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives.
501-1000 employees
H1B Sponsorship
Recursion has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (6)
2023 (5)
2022 (2)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$865.38MKey Investors
NVIDIAKinnevikLeaps by Bayer
2024-06-26Post Ipo Equity· $200M
2023-07-12Post Ipo Equity· $50M
2022-10-25Post Ipo Equity· $150M
Leadership Team
Ben Mabey
Chief Technology Officer
Najat Khan
Chief R&D Officer and Chief Commercial Officer, Board member
Recent News
MenloVentures
2025-12-31
Hartford Business Journal
2025-12-30
felicis.com
2025-12-29
Company data provided by crunchbase